Restoration of contact inhibition in human glioblastoma cell lines after MIF knockdown.
Standard
Restoration of contact inhibition in human glioblastoma cell lines after MIF knockdown. / Schrader, Jörg; Deuster, Oliver; Rinn, Birgit; Schulz, Martina; Kautz, Andreas; Dodel, Richard; Meyer, Bernhard; Al-Abed, Yousef; Balakrishnan, Karthikeyan; Reese, Jens P; Bacher, Michael.
in: BMC CANCER, Jahrgang 9, 2009, S. 464.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Restoration of contact inhibition in human glioblastoma cell lines after MIF knockdown.
AU - Schrader, Jörg
AU - Deuster, Oliver
AU - Rinn, Birgit
AU - Schulz, Martina
AU - Kautz, Andreas
AU - Dodel, Richard
AU - Meyer, Bernhard
AU - Al-Abed, Yousef
AU - Balakrishnan, Karthikeyan
AU - Reese, Jens P
AU - Bacher, Michael
PY - 2009
Y1 - 2009
N2 - BACKGROUND: Studies of the role of the cytokine macrophage-migration-inhibitory-factor (MIF) in malignant tumors have revealed its stimulating influence on cell-cycle progression, angiogenesis and anti-apoptosis. RESULTS: Here we show that in vitro targeting MIF in cultures of human malignant glioblastoma cells by either antisense plasmid introduction or anti-MIF antibody treatment reduced the growth rates of tumor cells. Of note is the marked decrease of proliferation under confluent and over-confluent conditions, implying a role of MIF in overcoming contact inhibition. Several proteins involved in contact inhibition including p27, p21, p53 and CEBPalpha are upregulated in the MIF antisense clones indicating a restoration of contact inhibition in the tumor cells. Correspondingly, we observed a marked increase in MIF mRNA and protein content under higher cell densities in LN18 cells. Furthermore, we showed the relevance of the enzymatic active site of MIF for the proliferation of glioblastoma cells by using the MIF-tautomerase inhibitor ISO-1. CONCLUSION: Our study adds another puzzle stone to the role of MIF in tumor growth and progression by showing the importance of MIF for overcoming contact inhibition.
AB - BACKGROUND: Studies of the role of the cytokine macrophage-migration-inhibitory-factor (MIF) in malignant tumors have revealed its stimulating influence on cell-cycle progression, angiogenesis and anti-apoptosis. RESULTS: Here we show that in vitro targeting MIF in cultures of human malignant glioblastoma cells by either antisense plasmid introduction or anti-MIF antibody treatment reduced the growth rates of tumor cells. Of note is the marked decrease of proliferation under confluent and over-confluent conditions, implying a role of MIF in overcoming contact inhibition. Several proteins involved in contact inhibition including p27, p21, p53 and CEBPalpha are upregulated in the MIF antisense clones indicating a restoration of contact inhibition in the tumor cells. Correspondingly, we observed a marked increase in MIF mRNA and protein content under higher cell densities in LN18 cells. Furthermore, we showed the relevance of the enzymatic active site of MIF for the proliferation of glioblastoma cells by using the MIF-tautomerase inhibitor ISO-1. CONCLUSION: Our study adds another puzzle stone to the role of MIF in tumor growth and progression by showing the importance of MIF for overcoming contact inhibition.
U2 - 10.1186/1471-2407-9-464
DO - 10.1186/1471-2407-9-464
M3 - SCORING: Zeitschriftenaufsatz
VL - 9
SP - 464
JO - BMC CANCER
JF - BMC CANCER
SN - 1471-2407
ER -